Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Royalty Pharma Stock Price, Quotes and Forecasts | NASDAQ:RPRX | Benzinga

Q: What sector and industry does Royalty Pharma (RPRX) operate in?

Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Explore Royalty Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RPRX.

Open	$32.16
Close	$32.45
Volume / Avg.	2.51M / 4.86M
Day Range	$32.15 - $32.60
52 Wk Range	24.05 - 34.32
Market Cap	$13.61B
P/E Ratio	13.19
Dividend Yield	2.72%
Exchange	NASDAQ
RSI	47
Short Interest	4.48%
Days to Cover	6.06

Recent News

4 Healthcare Stocks With Massive Gains—and More to Come

The American stock markets have had a rough month as investors remain jittery over international tariff fears. While this market downturn has affected most sectors of the economy, healthcare stocks are doing

MarketBeat

Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma

Biogen posted strong Q4 results, surpassing estimates, while forecasting a 2025 revenue decline. The company secured up to $250 million in R&D funding from Royalty Pharma.

Vandana Singh

US Stocks Dip As Powell Stays Cautious, Intel Climbs, Tesla Sinks To 11-Week Low: What's Driving Markets Tuesday?

U.S.

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$32.16
Close	$32.45
Volume / Avg.	2.51M / 4.86M
Day Range	$32.15 - $32.60
52 Wk Range	24.05 - 34.32
Market Cap	$13.61B
P/E Ratio	13.19
Dividend Yield	2.72%
Exchange	NASDAQ
RSI	47
Short Interest	4.48%
Days to Cover	6.06

About Royalty Pharma plc

Sector

Health Care

Industry

Pharmaceuticals

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of ...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Royalty Pharma (RPRX) stock?

You can purchase shares of Royalty Pharma (NASDAQ:RPRX) through any online brokerage.

View our list of the best stock brokerages

Who are Royalty Pharma (RPRX) competitors?

Other companies in Royalty Pharma’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).

What is the forecast, or price target, for Royalty Pharma (RPRX) stock?

Royalty Pharma has a consensus price target of $44.29.

What is the current price for Royalty Pharma (RPRX)?

The stock price for Royalty Pharma (NASDAQ: RPRX) is $32.29 last updated May 23, 2025 at 5:31 PM EDT.

Does Royalty Pharma (RPRX) pay a dividend?

A quarterly cash dividend of 0.22 per share of Class A Common Stock. The quarterly cash dividend was payable on June 10, 2025 to stockholders of record on May 16, 2025.

When is Royalty Pharma (NASDAQ:RPRX) reporting earnings?

Royalty Pharma’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Royalty Pharma (RPRX) going to split?

There is no upcoming split for Royalty Pharma.

What sector and industry does Royalty Pharma (RPRX) operate in?

Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Royalty Pharma Stock Price, Quotes and Forecasts

Royalty Pharma (RPRX) Forecast